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ReTINAL DISeASeS
Blindness and visual impairment due 
to retinal diseases
This General Assembly, compared to others 
in the past, had retinal diseases as a cause 
of visual impairment and blindness higher 
up on the agenda. This article summarises 
the main points made in relation to retinal 
diseases, in particular the challenge of 
diabetic retinopathy.
General overview on 
retinal diseases
A global epidemic of diabetes mellitus
Diabetes mellitus is a chronic disease that 
occurs when the pancreas does not produce 
enough insulin, a hormone that regulates blood 
sugar. Diabetes may be insulin-dependent, 
which is typically of early onset, or non insulin- 
dependent, when the body cannot effectively 
use the insulin it produces (maturity onset 
diabetes). Hyperglycaemia, or raised blood 
sugar, is a common effect of uncontrolled 
diabetes and over time leads to serious 
damage to many of the body’s systems, 
especially the eyes, kidneys, and nerves.1
The world is currently experiencing a global 
epidemic of this incurable disease. Current 
predictions estimate a doubling of the number 
affected from the current 171 million to an 
estimated 366 million by 2030 (Table 1). 
Global obesity maps presented at the meeting 
similarly showed a striking increase all over 
the world. The global increase of diabetes is 
attributed to increased life expectancy, 
urbanisation, and a change in life style and diet. 
Although previously recognised as a disease 
of the developed world, diabetes is becoming 
increasingly prevalent in the developing world 
and the majority of the burden from this disease 
is predicted to affect people of working age in 
low-income countries.2,3 In India alone, the 
number affected is expected to reach 80 million 
by 2030. As a shocking example, RD Ravindran 
cited the case of a 57-year-old physician who 
had had diabetes for 16 years and who 
presented with severe proliferative retinopathy. 
This highlighted not only a general lack of 
awareness, but also the fact that diabetic 
retinopathy may not be considered by some 
physicians to be an important complication. 
Ocular complications of diabetes: 
The main microvascular complication of 
diabetes in the eye is diabetic retinopathy 
(DR), which is found in almost 20% of newly 
diagnosed diabetic people. 
It is important to remember that diabetes 
is also a risk factor for cataract, so the 
retinopathy may only be evident once the 
cataract has been removed and a view of 
the posterior segment is possible.4 
Diabetic retinopathy is increasing as a 
cause of blindness throughout the world and 
data presented at the meeting suggests that 
DR accounts for an estimated 5% of the 
45 million blind people worldwide today. 
Age-related macular degeneration (AMD)
AMD was another retinal disease discussed 
and highlighted as a growing concern. It is a 
disorder predominantly affecting people over 
the age of 60. It affects the central part of the 
vision, which is essential for detailed tasks 
requiring fine vision, such as reading and 
recognising faces. 
By 2025, there will be twice as many older 
people worldwide as there were in 2000 (an 
increase from 606 million to 1.2 billion). 
Twenty-five years later, by 2050, the population 
of older people will be three times greater 
than in 2000, around two billion,5 and 
subsequently the number of people with 
AMD will increase significantly.
Figures presented by Serge Resnikoff 
suggest that AMD is already the third largest 
cause of blindness in the world, as it 
accounts for 9% of the 45 million blind 
people worldwide. 
treatment:
Unfortunately, although new and exciting 
treatment strategies have been demon-
strated to be beneficial in the active ‘wet’ 
form of AMD (intravitreal injections of anti-
vascular endothelial growth factor), they 
require repeated administration, are not 
curative, and are prohibitively expensive. 
On the other hand, smoking is an estab-
lished risk factor for AMD and tobacco 
control should be strongly advocated as a 
measure for the prevention of blindness. 
For example, in Australia, cigarette packets 
display a prominent warning saying: 
‘Smoking causes blindness’. Currently, 
smokers represent 25% of the worldwide 
population. Resnikoff explained that, if this 
figure were to fall from 25% to 15%, this 
would avoid 100,000 cases of blindness. 
Unfortunately, figures presented at the 
meeting show that, as the tobacco industry 
reaches new markets, the share of the 
worldwide consumption of cigarettes repre-
sented by developing countries is steadily 
increasing. Currently, developing countries 
account for approximately 70% of global 
tobacco consumption.   
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Table 1. Number of people with diabetes 
(in millions): top ten countries1
Country 2000 2030
(predicted)
India 31.7 79.4
China 20.8 42.3
USA 17.7 30.3
Indonesia 8.4 21.3
Japan 6.8 8.9
Pakistan 5.2 13.9
Russia 4.5 5.3
Brazil 4.6 11.3
Italy 4.3 5.3
Bangladesh 3.1 11.1
Worldwide 171 366
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Retinal detachment (RD)
The annual incidence of RD is estimated at 
10/100,000 per year, although there are 
regional variations. It was roughly estimated 
that, globally, 90 eyes are blinded by RD 
every hour. 
Risk factors for RD are increasing age, 
myopia, and cataract surgery. All these risk 
factors are becoming more common. 
Results from low-income countries show 
that many patients present only when they 
lose vision in both eyes. Delay in presen-
tation was acknowledged as a significant 
problem in the management of RD. It is often 
due to inadequate primary eye care and to 
misdiagnosis. Thus, it was highlighted that 
all ophthalmologists should be trained to 
recognise and manage RD appropriately.
Secondary prevention: 
screening for diabetic 
retinopathy
As blindness from DR is preventable, if caught 
and treated early (before symptomatic visual 
loss), DR provides an excellent opportunity for 
secondary prevention strategies, such as 
screening. 
A number of different screening models 
were discussed at the meeting. 
Scotland
In Scotland, 24% of the population is obese 
– a figure second only to the US – and it is 
estimated that 3–4% of the population has 
diabetes. The model used for the national 
screening programme was a system of 
‘gatekeepers’ on three levels, each with 
increasing expertise: a trainee screener 
(e.g. a nurse) assessed the presence or not 
of retinopathy, then a trained screener 
(e.g. an optometrist) assessed whether the 
patient with retinopathy needed to be 
referred for laser treatment, and this was 
confirmed by an ophthalmologist at the third 
level of screening.
However, this system is extremely costly 
and probably difficult to replicate in low- or 
middle-income countries. The automated 
grading of fundus photographs appears to 
be an exciting development, as it can 
reduce costs. One speaker mentioned a 
project comparing the cost-effectiveness of 
manual and automated grading for DR. It 
showed that, although manual grading 
was more accurate, it cost UK £4,000 
(US $5,750) per additional case detected.6 
India
The Aravind model in India uses a number of 
different methods to screen for DR. These 
range from screening for diabetes in the 
general population (nearly 230,000 screened) 
and then screening the suspects for DR, to 
using telemedicine facilities for patients 
known to have diabetes.
telemedecine:
Telemedicine was advocated as a tool to 
improve rural eye care, as there is a disparity 
in the distribution of eye care resources. Two 
applications were described:
•	a mobile model using a van with satellite 
connection to the Internet
•	a physician- and clinic-based model using 
a fixed broadband connection.
Both models operate in two modes: 
•	real time or interactive videoconferencing 
•	store and forward to base hospital later. 
Software designed for use within the screening 
process allows automatic generation of 
reports with possible treatment strategies. 
The results presented showed that nearly 
52,000 people were screened using the 
mobile method and DR was found in 
1,300, of which 76% had retinopathy 
detected for the first time. 
Latin America and the Caribbean
In Latin America, there has been no 
adequate situational analysis and there is 
limited logistic and technical skills. 
On the Caribbean island of Dominica, 
the DR screening programme utilises an 
itinerant ophthalmic technician with a digital 
fundus camera. Only 35% of the target 
population was screened in 2007 and, 
furthermore, compliance for referral was 
poor (44%). 
The figures were better in Medellin, 
Colombia, where nearly 70% of people 
known to have diabetes attended screening. 
Third-year trained residents graded the 
photographs. Retinal specialists provided 
treatment and treatment rates were high, 
with 25% of those found to have DR at 
screening receiving laser treatment.
Offering screening and treatment 
hand in hand
A particular concern expressed by all speakers 
and highlighted as a significant barrier was 
the practice of setting up a screening system 
without adequate treatment facilities being 
in place. Laser treatment is largely unavailable 
in many low-income countries. Even when 
it is available, it is often inaccessible and 
expensive.
Tertiary vitreoretinal 
services 
A new theme this year was the establishment 
of tertiary level vitreoretinal (VR) services. 
VR services (which offer predominantly pars 
plana vitrectomy) treat the complications of 
severe DR and/or patients with a retinal 
detachment (RD). 
Primary success of vitrectomy in low-income 
countries averaged 60–80% and nearly 
60% of patients achieved a visual acuity 
of 6/60 or better after surgery. 
Vitrectomy also has a place in the 
treatment of one of the serious complications 
of phacoemulsification cataract surgery – a 
‘dropped’ nucleus. 
Training in this speciality is a difficult issue 
and it was argued that a training unit in VR 
needs to be performing at least 200 retinal 
cases a year. 
Integration with other 
health sectors
Finally, all the speakers mentioned that services 
for retinal pathology needed to be better 
integrated with other health care sectors. 
This was a recurrent theme of the meeting. 
Services are currently disjointed; for 
example, orthopaedic doctors perform leg 
amputations in patients with diabetes, but 
they do not refer these patients for an eye 
examination.
Speakers advocated a better integration 
of blindness prevention strategies into 
national diabetes programmes.
1 There is a need for better public 
education and awareness (through 
community stakeholders and media).
2 There should be better coordination 
between eye care personnel and 
other health care personnel (e.g. eye 
teams should liaise with physicians in 
health centres).
3 Diabetes registers should be 
maintained and kept up to date.
4 Barriers to the use of services should 
be identified. For example, in Tanzania, 
although the check up was free, one-fifth 
of diabetic patients left the eye 
department after being given dilating 
drops and before being examined, 
because the waiting time was too long.
Diabetic retinopathy: 
key points
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